Intestinal parasitic infections are a significant health concern for individuals living with HIV/AIDS. These infections can exacerbate the complications associated with HIV, leading to increased ...
Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.